MENU
MRNS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Marinus Pharmaceuticals (MRNS) Earnings Date & Reports

A.I. Advisor
published Earnings

MRNS is expected to report earnings to fall 30.48% to -29 cents per share on March 11

Marinus Pharmaceuticals MRNS Stock Earnings Reports
Q4'24
Est.
$-0.29
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.04
Q1'24
Missed
by $0.03
Q4'23
Missed
by $0.12
The last earnings report on November 12 showed earnings per share of -41 cents, missing the estimate of -40 cents. With 1.14M shares outstanding, the current market capitalization sits at 13.19M.
View a ticker or compare two or three
MRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of innovative neuropsychiatric therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
100 Matsonford Road
Phone
+1 484 801-4670
Employees
165
Web
https://www.marinuspharma.com